Table 3.
Clinico-pathological features and septin 9 protein expression in colorectal cancer tissue (n = 40)
| Parameter | No. of cases (%) |
|---|---|
| Age | |
| ≦60 yr | 15 (37.5) |
| >60 yr | 25 (62.5) |
| Gender | |
| Male | 26 (65.0) |
| Female | 14 (35.0) |
| Location | |
| Right colon | 7 (17.5) |
| Left colon | 15 (37.5) |
| Rectum | 18 (45.0) |
| T stage | |
| T2 | 2 (5.0) |
| T3 | 12 (30.0) |
| T4 | 26 (65.0) |
| N stage | |
| N0 | 20 (50.0) |
| N1 | 7 (17.5) |
| N2 | 13 (32.5) |
| TNM stage | |
| II | 20 (50.0) |
| III | 20 (50.0) |
| Septin 9 of tissue | |
| Strong | 21 (52.5) |
| Weak | 19 (47.5) |
| mSEPT9 | |
| Positive | 23 (57.5) |
| Negative | 17 (42.5) |
| Recurrence/progression | |
| Occurrence | 19 (47.5) |
| Nothingness | 21 (52.5) |
mSEPT9: methylated septin 9 gene